High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis

Status Completed

Clinical Trial Summary

Primary biliary cirrhosis is a chronic cholestatic autoimmune liver disease with a progressive course that can lead to liver cirrhosis. There are few studies on dietary management in primary biliary cirrhosis and most of them have focused on micronutrients specifically vitamin D intake to prevent osteoporosis, and lipid control to prevent hyperlipidemia, but few recommendations have been made regarding a complete dietary approach. Fiber has been proven to increase the excretion of nitrogen products and consequently reduce its blood levels, and an adequate protein intake (1- 1.5 g per kg) has shown to decrease endogenous catabolism in cirrhotic patients.

The purpose of this study is to evaluate the impact of a high-protein, high-fiber diet in the nutritional status of patients with primary biliary cirrhosis.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01603199
Study type	Interventional
Source	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Contact
Status	Completed
Phase	N/A
Start date	September 2011
Completion date	June 2016

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04526665` - Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)	Phase 3
Recruiting	`NCT02931513` - sCD163 in PBC Patients - Assessment of Treatment Response
Active, not recruiting	`NCT02924701` - sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis
Completed	`NCT02659696` - Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis
Completed	`NCT02078882` - Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis	Phase 4
Completed	`NCT01389973` - A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid	Phase 2
Completed	`NCT01857284` - Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis	Phase 3
Completed	`NCT05374200` - Mind-body Wellness Intervention in Primary Biliary Cholangitis (PBC)	N/A
Recruiting	`NCT02937012` - Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders	Phase 3
Completed	`NCT02376335` - B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis	Phase 2
Recruiting	`NCT01662973` - Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis	Phase 1/Phase 2
Active, not recruiting	`NCT04751188` - A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis	Phase 3
Recruiting	`NCT04514965` - Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)
Recruiting	`NCT03668145` - Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis	N/A
Completed	`NCT02955602` - Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)	Phase 2
Completed	`NCT02557360` - Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis	Phase 4
Recruiting	`NCT01440309` - Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis	Phase 1
Completed	`NCT01249092` - Pentoxifylline for Primary Biliary Cirrhosis	Phase 2
Completed	`NCT01510860` - Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis	Phase 4
Completed	`NCT04604652` - Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis	Phase 2